Works by Skartved, Niels Jørgen Ø.

Results: 1
    1

    First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 3, p. 586, doi. 10.1007/s10637-022-01217-7
    By:
    • Berlin, Jordan;
    • Tolcher, Anthony W.;
    • Ding, Cliff;
    • Whisenant, Jennifer G.;
    • Horak, Ivan D.;
    • Wood, Debra L.;
    • Nadler, Paul I.;
    • Hansen, Ulla Holm;
    • Lantto, Johan;
    • Skartved, Niels Jørgen Ø.;
    • Pedersen, Mikkel W.;
    • Patnaik, Amita
    Publication type:
    Article